Literature DB >> 6129456

High-dose intravenous IgG in adults with autoimmune thrombocytopenia.

A C Newland, J G Treleaven, R M Minchinton, A H Waters.   

Abstract

A study of the effect of high-dose intravenous IgG in 25 adults with autoimmune thrombocytopenia confirmed the predictable rise in the platelet count seen during the infusion and previously reported in children. Unlike the data based on children, there was no sustained response unless the IgG infusion was closely associated with splenectomy. There was no correlation between the presence of platelet autoantibodies or the Ig class of the autoantibody and the pattern of response to the infusion. The initial platelet response appears to be the result of transient blockade of the reticuloendothelial system, including the macrophage Fc receptor mechanism. The long-term response in some patients requires another explanation and may be due to a more specific immunosuppressive effect of the high-dose IgG infusion. Splenectomy may have an additive effect by removing a major site of platelet autoantibody production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129456     DOI: 10.1016/s0140-6736(83)91738-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Cellular changes during the infusion of high dose intravenous immunoglobulin.

Authors:  A C Newland; M G Macey; P A Veys
Journal:  Blut       Date:  1989-07

Review 2.  [Is the administration of immunoglobulins following bone marrow transplantation indicated?].

Authors:  H G Klingemann
Journal:  Klin Wochenschr       Date:  1987-09-15

Review 3.  Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.

Authors:  S V Kaveri; G Dietrich; V Hurez; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

4.  Effective high-dose intravenous gammaglobulin therapy for passive immune thrombocytopenia in the neonate.

Authors:  A Stabile; M A Pesaresi; S M Sopo; G Segni
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

5.  Medical and surgical management of spontaneous hyphaema secondary to immune thrombocytopenia.

Authors:  C J McDonald; A Raafat; M J Mills; J A Rumble
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

6.  Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin.

Authors:  H Becker; G Mitropoulou; K Helmke
Journal:  Klin Wochenschr       Date:  1989-03-01

Review 7.  Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias.

Authors:  H I Atrah; R J Davidson
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

8.  Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice.

Authors:  R J Kurlander; J Hall
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

9.  Treatment of idiopathic West and Lennox-Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins.

Authors:  K van Rijckevorsel-Harmant; M Delire; M Rucquoy-Ponsar
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

10.  Prediction of the effect of immunoglobulin therapy in ITP.

Authors:  K Kawasugi; J Matsuda; T Abe
Journal:  Blut       Date:  1989-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.